ITGR Stock Analysis: Buy, Sell, or Hold?

ITGR - Integer Holdings Corporation

ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
$90.80
0.70 (0.78%) ▲
5d: -0.06%
30d: +0.89%
90d: +6.41%
BUY
MODERATE Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Jul 23, 2026 29d

Get Alerted When ITGR Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
💡 BUY OPPORTUNITY: ITGR shows positive signals but monitor for confirmation. Market pricing in 1.6% annual growth which appears achievable. Moderate conviction.
See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$125.53
Based on 8.0% avg growth
INTRINSIC VALUE TODAY
$77.94
Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 12.6x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: ITGR is currently trading at $90.80, which is considered fair relative to its 30-day fair value range of $89.45 to $91.92. The stock's valuation (Forward PE: 13.2) is in line with its historical norms (12.6). At these levels, the market is pricing in 1.6% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, ITGR is in a uptrend. The price is currently testing key support at $89.31. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (10th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $89.45 - $91.92
Company Quality Score 60/100 (BUY)
Options IV Signal 10th percentile (LOW)
Volume Confirmation HIGH
Confidence Score 74.6%

All Signals

  • NEUTRAL: Price in fair range
  • BULLISH: Options cheap (IV 10th percentile)
  • NEUTRAL: Mixed technical signals (40/100)
  • BULLISH: High volume confirmation
  • NEUTRAL: Near Wall St target ($97.56)
  • NEUTRAL: Market pricing in 1.6% annual earnings growth - fairly valued

Trading Range Analysis

30-Day Trading Range $89.45 - $91.92
Current vs Trading Range FAIR
Expected Move (7 Days) ±$5.04 (5.5%)

Support & Resistance Levels

Support Level $89.32
Resistance Level $94.76
Current Trend Uptrend
Technical data as of Jun 22, 2026

Fundamental Context

Forward P/E (Next Year Est.) 13.24
Wall Street Target $97.56 (+8.3%)
Revenue Growth (YoY) 0.5%
Earnings Growth (YoY) 52.9%
Profit Margin 7.6%
Valuation Premium vs History +1.6% premium
PE vs Historical 13.2 vs 12.6 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +1.6% (market-implied from PE analysis)
1-Year Target $91.54 (+2%)
2-Year Target $93.01 (+3%)
3-Year Target $94.49 (+5%)
3-Yr Target (if PE normalizes) (PE: 13→13) PE COMPRESSION $89.96 (0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 21.8, Growth: 11.9%) $207.87 (+131%)
Base: (SPY PE: 13.2, Growth: 11.9%) $126.32 (+40%)
Bear: (PE: 11.2, Growth: 11.9%) $107.37 (+19%)
📈 Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (22x PE), but valuation improves significantly next year (13x PE) as earnings recover.
Trailing PE: 22.37 | Current EPS (TTM): $4.03
Bull Case $167.50 (+86%)
Analyst growth 68.9%, PE expands to 24.6
Base Case $152.28 (+69%)
Market implied 68.9%, PE stable at 22.4
Bear Case $61.30 (-32%)
Severe decline -20.0%, PE contracts to 19.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: June 23, 2026 10:07 AM ET
Data refreshes hourly during market hours. Next update: 11:07 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Tommy P Thomas SELL 825 shares 2026-03-13

Unlock Insider Activity

See real-time buying/selling by company executives for ITGR.

Create Free Account

Already have an account? Log In

Top Rated Medical Devices Stocks

Top-rated stocks in Medical Devices by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
BSX
Boston Scientific Corp
STRONG BUY
34 analysts
$77 52 HOLD
DXCM
DexCom Inc
STRONG BUY
27 analysts
$85 57 HOLD
SYK
Stryker Corporation
BUY
32 analysts
$387 61 BUY
PODD
Insulet Corporation
STRONG BUY
24 analysts
$242 60 HOLD
MDT
Medtronic PLC
BUY
32 analysts
$98 63 BUY

Advanced ITGR Option Strategies

Professional options setups generated by AI based on today's ITGR price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for ITGR

ITGR Technical Chart ITGR Price Prediction ITGR Earnings Date ITGR Investment Advisor ITGR Fair Price Analyzer ITGR Options Advisor ITGR Options Chain ITGR Options Analysis ITGR Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals